These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 14696814)

  • 21. Miltefosine for Indian visceral leishmaniasis.
    Roca B
    N Engl J Med; 2003 Feb; 348(9):857-8; author reply 857-8. PubMed ID: 12608397
    [No Abstract]   [Full Text] [Related]  

  • 22. Hemophagocytic lymphohistiocytosis associated with visceral leishmaniasis.
    Tapisiz A; Belet N; Ciftçi E; Ince E; Dogru U
    J Trop Pediatr; 2007 Oct; 53(5):359-61. PubMed ID: 17626064
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lingual leishmaniasis complicating visceral disease.
    Mazumder SA; Pandey S; Brewer SC; Baselski VS; Weina PJ; Land MA; Fleckenstein JM
    J Travel Med; 2010; 17(3):212-4. PubMed ID: 20536896
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Highly effective oral amphotericin B formulation against murine visceral leishmaniasis.
    Wasan KM; Wasan EK; Gershkovich P; Zhu X; Tidwell RR; Werbovetz KA; Clement JG; Thornton SJ
    J Infect Dis; 2009 Aug; 200(3):357-60. PubMed ID: 19545212
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comment on: Unresponsiveness to AmBisome in some Sudanese patients with kala-azar.
    de Górgolas M
    Trans R Soc Trop Med Hyg; 2007 Oct; 101(10):1054; author reply 1054-5. PubMed ID: 17651771
    [No Abstract]   [Full Text] [Related]  

  • 26. [First-line liposomal amphotericin B for pediatric visceral leishmaniasis in southern France].
    Minodier P; Robert S; Noël G; Blanc P; Retornaz K; Garnier JM
    Arch Pediatr; 2005 Jul; 12(7):1102-8. PubMed ID: 15964525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A case of antimony resistant kala-azar cured with amphotericin B].
    Chen SB; Yang CM; Zhang CJ
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2007 Jun; 25(3):inside front page. PubMed ID: 18038767
    [No Abstract]   [Full Text] [Related]  

  • 28. Visceral leishmaniasis associated hemophagocytic syndrome in patients with chronic granulomatous disease.
    Martín A; Marques L; Soler-Palacín P; Caragol I; Hernandez M; Figueras C; Español T
    Pediatr Infect Dis J; 2009 Aug; 28(8):753-4. PubMed ID: 19633526
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Post-kala-azar dermal Leishmaniasis and uveitis in an HIV-positive patient.
    Ramos A; Cruz I; Muñez E; Salas C; Fernández A; Alvarez-Espejo T
    Infection; 2008 Mar; 36(2):184-6. PubMed ID: 18327683
    [No Abstract]   [Full Text] [Related]  

  • 30. Early efficacy of liposomal amphotericin B in the treatment of visceral leishmaniasis.
    Castagnola E; Davidson RN; Fiore P; Tasso L; Rossi G; Mangraviti S; Di Martino L; Scotti S; Cascio A; Pempinello R; Gradoni L; Giacchino R
    Trans R Soc Trop Med Hyg; 1996; 90(3):317-8. PubMed ID: 8758092
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of visceral leishmaniasis with a 10 day course of L-ampB-LRC (Bombay), a liposomal amphotericin B.
    Bodhe PV; Pathare AV; Kshirsagar NA; Pandya SK
    J Assoc Physicians India; 1996 Mar; 44(3):222. PubMed ID: 9251329
    [No Abstract]   [Full Text] [Related]  

  • 32. Visceral leishmaniasis: rapid response to AmBisome treatment.
    Smith OP; Hann IM; Cox H; Novelli V
    Arch Dis Child; 1995 Aug; 73(2):157-9. PubMed ID: 7574862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and tolerance of amphotericin B in a lipid emulsion in the treatment of visceral leishmaniasis in AIDS patients.
    Petit N; Parola P; Dhiver C; Gastaut JA
    J Antimicrob Chemother; 1996 Jul; 38(1):154-7. PubMed ID: 8858471
    [No Abstract]   [Full Text] [Related]  

  • 34. [Treatment of visceral Leismaniasis in HIV patients with a new regimen of liposomal amphotericin].
    Canora Lebrato J; Troncoso García E; Escobar T; Hernández Quero J
    Med Clin (Barc); 2001 Mar; 116(10):395. PubMed ID: 11333677
    [No Abstract]   [Full Text] [Related]  

  • 35. Visceral leishmaniasis in India.
    Bryceson A
    Lancet; 2000 Dec; 356(9245):1933. PubMed ID: 11130411
    [No Abstract]   [Full Text] [Related]  

  • 36. Hemophagocytic lymphohistiocytosis associated with H1N1 virus infection and visceral leishmaniasis in a 4.5-month-old infant.
    Ay Y; Yildiz B; Unver H; Karapinar DY; Vardar F
    Rev Soc Bras Med Trop; 2012 Jun; 45(3):407-9. PubMed ID: 22760147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A 6 day course of liposomal amphotericin B in the treatment of infantile visceral leishmaniasis: the Italian experience.
    Cascio A; di Martino L; Occorsio P; Giacchino R; Catania S; Gigliotti AR; Aiassa C; Iaria C; Giordano S; Colomba C; Polara VF; Titone L; Gradoni L; Gramiccia M; Antinori S
    J Antimicrob Chemother; 2004 Jul; 54(1):217-20. PubMed ID: 15150166
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Foamy histiocytes in a patient with visceral leishmaniasis after treatment with liposomal amphotericin B.
    Tavil B; Seçmeer G; Ozen H; Cengiz AB; Unal S; Gürgey A
    Turk J Pediatr; 2008; 50(1):67-9. PubMed ID: 18365595
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Subacute Mediterranean visceral leishmaniosis treated with a single injection of amphotericin B].
    Vandenbos F; Marty P; Rosenthal E; Delaunay P; Dellamonica P; Le Fichoux Y
    Presse Med; 2004 Sep; 33(15):1009-10. PubMed ID: 15523248
    [No Abstract]   [Full Text] [Related]  

  • 40. Visceral leishmaniasis caused by Leishmania infantum in Thailand.
    Maharom P; Siripattanapipong S; Mungthin M; Naaglor T; Sukkawee R; Pudkorn R; Wattana W; Wanachiwanawin D; Areechokchai D; Leelayoova S
    Southeast Asian J Trop Med Public Health; 2008 Nov; 39(6):988-90. PubMed ID: 19062685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.